Green synthesized selenium nanoparticles using Spermacoce hispida as carrier of s-allyl glutathione: to accomplish hepatoprotective and nephroprotective activity against acetaminophen toxicity
Source abstract
Abstract
s-allyl glutathione (SAG) an analogue of glutathione is explored for its antioxidative and liver protection property in recent years. Selenium nanoparticles (Sh-SeNPs) were synthesized using medicinal plant Spermacoce hispida and conjugated with SAG (SAG-Sh-SeNPs). SAG-Sh-SeNPs and Sh-SeNPs were characterized using by Fourier transform infrared spectroscopy, Transmission electron microscopy, Energy dispersive X-ray analysis, X-ray diffraction analysis and zeta potential analysis. SAG-Sh-SeNPs and Sh-SeNPs were evaluated against acetaminophen (APAP)-induced liver and kidney injury in rat. Pretreatment of NPs attenuated the APAP toxicity-induced elevation of kidney and liver injury markers in the blood circulation. Histological observation showed that NPs pretreatment protected the morphology of liver and kidney tissue. SAG-Sh-SeNPs showed enhanced protection against APAP toxicity in comparison to Sh-SeNPs due to synergistic effect of SAG and Sh-SeNPs. SAG-Sh-SeNPs protected the liver and kidney against APAP toxicity through reducing oxidative stress, enhancing endogenous antioxidants and protecting mitochondrial functions.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Drug-Induced Hepatotoxicity and Protection · Chemotherapy-induced organ toxicity mitigation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biochemistry, Molecular Therapeutics Laboratory, Periyar University
References (49)
Show source-provided references
1. 10.1081/CLT-10010541310.1081/CLT-100105413 ↗
2. 10.1080/1354750X.2017.131561610.1080/1354750X.2017.1315616 ↗
3. 10.1016/j.redox.2018.04.01910.1016/j.redox.2018.04.019 ↗
4. 10.1073/pnas.81.5.132710.1073/pnas.81.5.1327 ↗
5. 10.1080/0049825080251283010.1080/00498250802512830 ↗
6. 10.1006/niox.2001.040410.1006/niox.2001.0404 ↗
7. 10.1021/tx980034910.1021/tx9800349 ↗
8. 10.1016/j.bcp.2009.07.01610.1016/j.bcp.2009.07.016 ↗
9. 10.1002/hep.2043710.1002/hep.20437 ↗
10. 10.1093/toxsci/kfv31910.1093/toxsci/kfv319 ↗
11. 10.1007/s00204-016-1692-010.1007/s00204-016-1692-0 ↗
12. 10.1016/j.fct.2017.08.02010.1016/j.fct.2017.08.020 ↗
13. 10.3109/03602532.2011.60268810.3109/03602532.2011.602688 ↗
14. 10.1007/s11095-013-1007-610.1007/s11095-013-1007-6 ↗
15. 10.1016/j.trsl.2018.02.00310.1016/j.trsl.2018.02.003 ↗
16. 10.1007/s12011-016-0748-610.1007/s12011-016-0748-6 ↗
17. 10.1080/21691401.2017.134794110.1080/21691401.2017.1347941 ↗
18. 10.1080/21691401.2018.145225010.1080/21691401.2018.1452250 ↗
19. 10.1166/jbn.2014.198510.1166/jbn.2014.1985 ↗
20. 10.1080/21691401.2017.138974910.1080/21691401.2017.1389749 ↗
21. 10.1088/2043-6254/aa9f4d10.1088/2043-6254/aa9f4d ↗
22. 10.1021/mp500431r10.1021/mp500431r ↗
23. 10.1007/s00044-014-1263-y10.1007/s00044-014-1263-y ↗
24. Takemura S, Azuma H, Osada-Oka M, et al. S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats. Am J Physiol Gastrointest Liver Physiol. 2017;2017:. ajpgi. 00023
25. 10.1016/j.etap.2017.12.00610.1016/j.etap.2017.12.006 ↗
26. 10.1021/nn202452c10.1021/nn202452c ↗
27. 10.1038/nprot.2006.47810.1038/nprot.2006.478 ↗
28. 10.1186/1471-2407-6-26710.1186/1471-2407-6-267 ↗
29. 10.1007/s11010-006-0640-310.1007/s11010-006-0640-3 ↗
30. 10.1042/bj099066710.1042/bj0990667 ↗
31. 10.1016/0003-9861(59)90090-610.1016/0003-9861(59)90090-6 ↗
32. 10.1016/0076-6879(79)62181-X10.1016/0076-6879(79)62181-X ↗
33. 10.1126/science.179.4073.58810.1126/science.179.4073.588 ↗
34. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21:130–132.
35. 10.17485/ijst/2016/v9i4/8049910.17485/ijst/2016/v9i4/80499 ↗
36. 10.1373/clinchem.2006.07887310.1373/clinchem.2006.078873 ↗
37. 10.1016/0009-8981(94)90270-410.1016/0009-8981(94)90270-4 ↗
38. 10.20964/2016.10.3010.20964/2016.10.30 ↗
39. 10.1016/j.etap.2014.10.01910.1016/j.etap.2014.10.019 ↗
40. 10.1016/j.etap.2016.01.01210.1016/j.etap.2016.01.012 ↗
41. 10.1016/j.biopha.2018.04.17510.1016/j.biopha.2018.04.175 ↗
42. 10.1016/j.yclnex.2018.02.00210.1016/j.yclnex.2018.02.002 ↗
43. 10.1124/dmd.107.01554510.1124/dmd.107.015545 ↗
44. 10.1016/j.fct.2017.02.02110.1016/j.fct.2017.02.021 ↗
45. 10.1016/j.fct.2009.11.03910.1016/j.fct.2009.11.039 ↗
46. 10.1016/j.lfs.2004.02.00410.1016/j.lfs.2004.02.004 ↗
47. 10.1016/j.freeradbiomed.2013.02.01810.1016/j.freeradbiomed.2013.02.018 ↗
48. 10.1271/bbb.11057910.1271/bbb.110579 ↗
49. 10.1093/toxsci/kfi33610.1093/toxsci/kfi336 ↗